earnings

Clovis Oncology's Sales Growth Slows in Q4
Clovis Oncology's Sales Growth Slows in Q4
Motley Fool
Clovis Oncology
earnings
Flag link:
Ortho, spine players Smith & Nephew, NuVasive and Globus post Q4 results
Ortho, spine players Smith & Nephew, NuVasive and Globus post Q4 results
Medtech Dive
devices
earnings
Smith & Nephew
NuVasive
Globus Medical
Flag link:
Emergent BioSolutions Reports Mixed Results for Q4
Emergent BioSolutions Reports Mixed Results for Q4
Motley Fool
Emergent BioSolutions
earnings
Flag link:
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Motley Fool
Repligen
earnings
gene therapy
Flag link:
How Masimo Blew Past Wall Street Estimates in Q4
How Masimo Blew Past Wall Street Estimates in Q4
Motley Fool
Masimo
earnings
devices
Flag link:
Why Elanco Animal Health's Q4 Results Didn't Have Much Bite
Why Elanco Animal Health's Q4 Results Didn't Have Much Bite
Motley Fool
Elanco
animal health
earnings
Flag link:
What's Behind Bausch Health's Disappointing Q4 Earnings Results
What's Behind Bausch Health's Disappointing Q4 Earnings Results
Motley Fool
earnings
devices
Motley Fool
Flag link:
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
Motley Fool
Bluebird Bio
earnings
Flag link:
Medtronic misses revenue estimates as TAVR position falters
Medtronic misses revenue estimates as TAVR position falters
Medtech Dive
Medtronic
devices
earnings
Flag link:
AstraZeneca cans cancer pipeline efforts
AstraZeneca cans cancer pipeline efforts
Fierce Biotech
AstraZeneca
earnings
R&D
cancer
oncology
Flag link:
How Zoetis Beat Expectations Yet Again with Its Q4 Results
How Zoetis Beat Expectations Yet Again with Its Q4 Results
Motley Fool
Zoetis
earnings
animal health
Flag link:
Incyte Earnings, Revenue Beat in Q4
Incyte Earnings, Revenue Beat in Q4
Yahoo/Investing.com
Incyte
earnings
Flag link:
Teva Pharmaceutical Reports a Step Back in 2019
Teva Pharmaceutical Reports a Step Back in 2019
Motley Fool
Teva Pharmaceutical
earnings
Flag link:
How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
How Allergan Beat Estimates in What's Likely Its Last Quarterly Update
Motley Fool
Allergan
earnings
Flag link:
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
BioSpace
earnings
Bristol-Myers Squibb
AbbVie
Novo Nordisk
Merck
GSK
Seattle Genetics
Flag link:
Gilead Sciences: Still on the Path to Recovery
Gilead Sciences: Still on the Path to Recovery
Motley Fool
Gilead Sciences
earnings
Flag link:
Myriad Genetics CEO Mark Capone Resigns
Myriad Genetics CEO Mark Capone Resigns
Motley Fool
Myriad Genetics
Mark Capone
Pharma CEOs
earnings
Flag link:
AbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost Sales
AbbVie Tops Q4 Profit Forecast, Sees Solid 2020 as New Drugs Boost Sales
TheStreet.com
AbbVie
earnings
Flag link:
Seattle Genetics Reports Q4 Earnings Results
Seattle Genetics Reports Q4 Earnings Results
Motley Fool
Seattle Genetics
earnings
Flag link:
Abiomed Crushed Its Earnings Estimates, but the Market Wasn't Impressed
Abiomed Crushed Its Earnings Estimates, but the Market Wasn't Impressed
Motley Fool
earnings
Abiomed
devices
Flag link:

Pages